Monday, December 1, 2008 - 8:59PM EST

Surgical Therapy

11. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.

Author
Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M;
Institution
Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Journal
Jpn J Clin Oncol. 2008 May;38(5):360-4.
Abstract URL
Click here to view abstract

12. Incidence and risk factors of stomal complications in patients undergoing cystectomy with ileal conduit urinary diversion for bladder cancer.

Author
Kouba E; Sands M; Lentz A; Wallen E; Pruthi RS;
Institution
Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Journal
J Urol. 2007 Sep;178(3 Pt 1):950-4. Epub 2007 Jul 16.
Abstract URL
Click here to view abstract

13. Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients.

Author
Huguet J; Monllau V; Sabate S; Rodriguez-Faba O; Algaba F; Palou J; Villavicencio H;
Institution
Urology Department, Fundacio Puigvert, Barcelona, Spain. jhuguet@fundacio-puigvert.es <jhuguet@fundacio-puigvert.es>
Journal
Eur Urol. 2008 Apr;53(4):785-92 discussion 792-3. Epub 2007 Jul 5.
Abstract URL
Click here to view abstract

14. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions.

Author
Nieuwenhuijzen JA; de Vries RR; Bex A; van der Poel HG; Meinhardt W; Antonini N; Horenblas S;
Institution
Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Journal
Eur Urol. 2008 Apr;53(4):834-42; discussion 842-4. Epub 2007 Sep 18.
Abstract URL
Click here to view abstract

15. Gastrointestinal function and metabolic control after construction of an orthotopic ileal neobladder in bladder cancer.

Author
Thorstenson A; Jacobsson H; Onelov E; Holst JJ; Hellstrom PM; Kinn AC;
Institution
Department of Molecular Medicine, Section of Urology, Stockholm, Sweden. andreas.thorstenson@karolinska.se
Journal
Scand J Urol Nephrol. 2007;41(1):14-9.
Abstract URL
Click here to view abstract

16. A pilot study of the assessment of the quality of life, functional results, and complications in patients with an ileal neobladder for invasive bladder cancer.

Author
Harano M; Eto M; Nakamura M; Hasegawa Y; Kano M; Yamaguchi A; Naito S;
Institution
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukoka, Japan.
Journal
Int J Urol. 2007 Feb;14(2):112-7.
Abstract URL
Click here to view abstract

17. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.

Author
Sogni F; Brausi M; Frea B; Martinengo C; Faggiano F; Tizzani A; Gontero P;
Institution
Clinica Urologica, Universita del Piemonte Orientale, Novara, Italy.
Journal
Urology. 2008 May;71(5):919-23. Epub 2008 Mar 20.
Abstract URL
Click here to view abstract

18. Influence of post-cystectomy complications on cost and subsequent outcome.

Author
Konety BR; Allareddy V;
Institution
Department of Urology, University of California-San Francisco, San Francisco, California 94143-1695, USA.
Journal
J Urol. 2007 Jan;177(1):280-7; discussion 287.
Abstract URL
Click here to view abstract

19. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.

Author
Nielsen ME; Shariat SF; Karakiewicz PI; Lotan Y; Rogers CG; Amiel GE; Bastian PJ; Vazina A; Gupta A; Lerner SP; Sagalowsky AI; Schoenberg MP; Palapattu GS;
Institution
The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland, USA. nielsen@jhmi.edu
Journal
Eur Urol. 2007 Mar;51(3):699-706; discussion 706-8. Epub 2006 Nov 13.
Abstract URL
Click here to view abstract
Pages: 1 2 3